Acrivon Therapeutics announced the appointment of Santhosh Palani, Ph.D., CFA, to its board of directors. Palani is a former investment partner and a current advisory partner at PFM Health Sciences
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACRV:
- Acrivon Therapeutics initiated with an Outperform at JMP Securities
- Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference
- Acrivon Therapeutics Welcomes New Board Member Dr. Magovcevic-Liebisch
- Acrivon Therapeutics appoints Magovcevic to board of directors
- Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
